Loading…
Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
99pct
405d open
vs 1,187 other HRES bills in the 115th — cohort avg 17d
Expresses support for efforts to: (1) exempt sunscreen from over-the-counter medication bans in schools, and (2) encourage health care professionals to educate parents and children about sun-safe behaviors. Encourages schools to allow students to possess sunscreen without restriction and without physician authorization.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2018 · fourth_quarter · Pharmacy
ASSUMING FIRST SPONSORSHIP - Mr. Joyce asked unanimous consent that he may hereafter be considered as the primary sponsor of H.Res 282, a bill originally introduced by Representative Dent, for the purpose of adding cosponsors and requesting reprintings under clause 7 of rule XII.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Insanitary Conditions at Compounding Facilities Support for HRES 282: OTC sunscreen use at school
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; H.R. 4122 & S. 2006, the Breast Density & Mammography Reporting Act; and H.R.820 & S.292, the Childhood Cancer STAR Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. The proposed Medical Records Fairness Act (no number yet). Issues regarding the Affordable Care Act premium tax credits and catastrophic plans, HR 6311. Issues regarding protections for people with pre-existing conditions, including S. 3388, HR 6898, and H. Res. 1066. Resolutions to disapprove the short-term rule, H.J. Res 140 and S. J. Res. 63. Advocacy against including the Association Health Plan provision of the House Farm bill in the conference report, H.R. 2 and s. 3042 (section 6004 of the House-passed version of the legislation). Issues involving patient navigation, including the Patient Navigation Assistance Act, HR 6808. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018. H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018. Issues related to caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act, H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for.
Client expense: $1,610,710 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2018 · fourth_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2019 Ag-FDA Appropriations bills and reports (H.R. 5961, S.2976); H.Res.282 on sunscreen use in schools; Sunscreen provisions in H.R. 5333, the Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018, and S.2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act; issues related to state bans on sunscreen ingredients.
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support H.R. 5958, Phair Pricing Act. Support H.R. 6689/S. 3368, Ensuring Lasting Smiles Act. Advocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841/H.R. 5773/Section 6062 of H.R. 6 (SUPPORT for Patients & Communities Act), Standardizing Electronic Prior Authorization for Safe Prescribing Act and S. 2908, Electronic Prior Authorization in Medicare Part D Act. Support sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act. Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program. Advocate for the continued funding of Community Health Centers. Advocate against including physician advocacy and membership organization in the Physician Payment Sunshine Act requirements as originally included in S. 3000; advocated against inclusion in S. Amendment 4013 to H.R. 6.
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support S. 2553, Know the Lowest Prices Act. Support S. 2554, Patient Right to Know Drug Prices Act. Support H.R. 5958, Phair Pricing Act. Support H.R. 5343, Prescription Transparency Act. Support H.R. 6689/S. 3368, Ensuring Lasting Smiles Act. Advocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841/H.R. 5773/Section 6062 of H.R. 6 (SUPPORT for Patients & Communities Act), Standardizing Electronic Prior Authorization for Safe Prescribing Act and S. 2908, Electronic Prior Authorization in Medicare Part D Act. Support sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act. Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program. Advocate for the continued funding of Community Health Centers. Advocate against including physician advocacy and membership organization in the Physician Payment Sunshine Act requirements as originally included in S. 3000; advocated against inclusion in S. Amendment 4013 to H.R. 6.
Client expense: $500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2019 Ag-FDA Appropriations bills and reports (H.R. 5961, S.2976); H.Res.282 on sunscreen use in schools; Sunscreen provisions in H.R. 5333, the Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018, and S.2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act; issues related to state bans on sunscreen ingredients.
Client expense: Not reported · Firm income: $30,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act Support S. 2553, Know the Lowest Prices Act Support S. 2554, Patient Right to Know Drug Prices Act Support H.R. 5958, Phair Pricing Act Advocate for relief for from pior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841/H.R. 5773/Section 6062 of H.R. 6 (SUPPORT for Patients & Communities Act), Standardizing Electronic Prior Authorization for Safe Prescribing Act and S. 2908, Electronic Prior Authorization in Medicare Part D Act Support sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program. Advocate for the continued funding of Community Health Centers.
2018 · second_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2019 Ag-FDA Appropriations bill (H.R. 5961, S.2976); H.Res.282 on sunscreen use in schools; Sunscreen provisions in H.R. 5333, the Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018, and S.2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act; issues related to state bans on sunscreen ingredients.
Client expense: Not reported · Firm income: $30,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Tanning Bed Cancer Control Act, Issues pertaining to the regulation of tanning beds Tanning Bed regulation issues Medical research issues S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2019, provisions related to skin cancer and melanoma H.Res.282, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection, provisions related to skin cancer
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act Support S. 2553, Know the Lowest Prices Act Support S. 2554, Patient Right to Know Drug Prices Act Advocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act Support sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program. Advocate for the continued funding of Community Health Centers. Advocate for funding the Community Health Center Fund in 2018 and 2019 in the Bipartisan Budget Act of 2018, H.R. 1892. Support maintaining the Prevention and Public Health Fund (PPHF); opposed provisions to reducing PPHF in H.R.1892.
2018 · first_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act Support S. 2553, Know the Lowest Prices Act Support S. 2554, Patient Right to Know Drug Prices Act Advocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act Support sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program. Advocate for the continued funding of Community Health Centers. Advocate for funding the Community Health Center Fund in 2018 and 2019 in the Bipartisan Budget Act of 2018, H.R. 1892. Support maintaining the Prevention and Public Health Fund (PPHF); opposed provisions to reducing PPHF in H.R.1892.
2018 · first_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2019 Ag-FDA Appropriations bill; nominations to HHS and FDA; H.Res.282 on sunscreen use in schools; Sunscreen provisions in H.R. 5333, the Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018, and S.2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Tanning Bed Cancer Control Act, Issues pertaining to the regulation of tanning beds Tanning Bed regulation issues Medical research issues Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2019, provisions related to skin cancer and melanoma H.Res.282, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection, provisions related to skin cancer
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for reform of insurers prior authorization practices. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program. Advocate for the continued funding of Community Health Centers
Client expense: $340,000 · Firm income: Not reported
2017 · fourth_quarter · Health Issues
Tanning Bed Cancer Control Act, Issues pertaining to the regulation of tanning beds Tanning Bed regulation issues Medical research issues H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, provisions related to skin cancer and melanoma H.Res.282, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection, provisions related to skin cancer
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) HR 4434 - Fix NICS Act of 2017 HR 4206 - Medicare Care Coordination Improvement Act HR 2843/S 1317 - Medicaid and CHIP Quality Improvement Act of 2017 (MACRA) S. 2059 - EHR Regulatory Relief Act H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Childrens Health Insurance (CHIP) funding/extension Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) Firearms/injury prevention initiatives General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research and Funding Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking PTAC APM Hearings Opioids Qualified clinical data registry (QCDR) Various VA Health bills
2017 · fourth_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) HR 4434 - Fix NICS Act of 2017 HR 4206 - Medicare Care Coordination Improvement Act HR 2843/S 1317 - Medicaid and CHIP Quality Improvement Act of 2017 (MACRA) S. 2059 - EHR Regulatory Relief Act H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Childrens Health Insurance (CHIP) funding/extension Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) Firearms/injury prevention initiatives General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research and Funding Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking PTAC APM Hearings Opioids Qualified clinical data registry (QCDR) Various VA Health bills
2017 · fourth_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) HR 4434 - Fix NICS Act of 2017 HR 4206 - Medicare Care Coordination Improvement Act HR 2843/S 1317 - Medicaid and CHIP Quality Improvement Act of 2017 (MACRA) S. 2059 - EHR Regulatory Relief Act H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Childrens Health Insurance (CHIP) funding/extension Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) Firearms/injury prevention initiatives General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research and Funding Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking PTAC APM Hearings Opioids Qualified clinical data registry (QCDR) Various VA Health bills
2017 · fourth_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) HR 4434 - Fix NICS Act of 2017 HR 4206 - Medicare Care Coordination Improvement Act HR 2843/S 1317 - Medicaid and CHIP Quality Improvement Act of 2017 (MACRA) S. 2059 - EHR Regulatory Relief Act H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Childrens Health Insurance (CHIP) funding/extension Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) Firearms/injury prevention initiatives General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research and Funding Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking PTAC APM Hearings Opioids Qualified clinical data registry (QCDR) Various VA Health bills
2017 · fourth_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; H.R. 3268 and S.1603, FY 2018 Ag-FDA Appropriations bill; nominations to HHS and FDA; H.Res.282 on sunscreen use in schools; House and Senate draft legislation to reform over-the-counter monograph approvals.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; the FY 2017 & FY 2018 Ag-FDA Appropriations bill; nominations to HHS and FDA; H.Res.282 on sunscreen use in schools; House and Senate draft legislation to reform over-the-counter monograph approvals.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Health Issues
Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for the sense of Congress that states should expand access to sun safety products and practices. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Advocate for generic drug approval reform in H.R. 2430 /S. 934, FDA Reauthorization Act. Support H.R. 749, the Lower Drug Costs through Competition Act. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support S. 637, C-THRU Act. Support S. 297, Increasing Competition in Pharmaceuticals Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Advocate for reform of insurers prior authorization practices. Advocate for access to dermatological procedures for veterans through the Veterans Choice Program.
2017 · third_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking Various VA Health bills
Client expense: $17,890 · Firm income: Not reported
2017 · third_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking Various VA Health bills
Client expense: $17,890 · Firm income: Not reported
2017 · third_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking Various VA Health bills
Client expense: $45,190 · Firm income: Not reported
2017 · third_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking Various VA Health bills
Client expense: $45,190 · Firm income: Not reported
2017 · third_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking Various VA Health bills
Client expense: $17,890 · Firm income: Not reported
2017 · third_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880/S. 1022 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act H.R. 501 - VA Transparency Enhancement Act of 2017 S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools H.R. 1676 - Palliative Care and Hospice Education and Training Act H.R. 3120 a bill to ease meaningful use (MU) reporting requirements Section 1877 of the Social Security Act (Stark Law) H.Res.503 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high-quality, patient-centered cancer care. Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid Physician Fee Schedule MIPS Benchmarking Various VA Health bills
Client expense: $17,890 · Firm income: Not reported
2017 · second_quarter · Health Issues
Lobby members of the House to write to FDA regarding the agencys final guidance document on office-use compounding. Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for the sense of Congress that states should expand access to sun safety products and practices. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Support, S. Res. 182, a resolution designating May 2017 as "Melanoma Awareness Month. Advocate for generic drug approval reform in H.R. 2430/S. S.934, FDA Reauthorization Act. Support H.R. 749, the Lower Drug Costs through Competition Act. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support S. 637, C-THRU Act. Support S. 297, Increasing Competition in Pharmaceuticals Act.
Client expense: $390,000 · Firm income: Not reported
2017 · second_quarter · Medical/Disease Research/Clinical Labs
Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; the FY 2017 & FY 2018 Ag-FDA Appropriations bill; nominations to HHS and FDA; H.Res.282 on sunscreen use in schools; House and Senate draft legislation to reform over-the-counter monograph approvals.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid
Client expense: $26,399 · Firm income: Not reported
2017 · second_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid
Client expense: $26,399 · Firm income: Not reported
2017 · second_quarter · Health Issues
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid
Client expense: $173,003 · Firm income: Not reported
2017 · second_quarter · Medicare/Medicaid
H.R. 1628 - American Health Care Act of 2017/Senate Better Care Reconciliation Act H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017 H.R. 880 - Mission Zero Act H.R. 1215 - Protecting Access to Care Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 1017 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R. 820 - Childhood Cancer STAR Act H.R. 1565 - Saving Lives Saving Costs Act S. 251 - Protecting Medicare from Executive Action Act of 2017 H. R. 1704 - ACCESS Act of 2017 H.R. 2906/S. 1351 - Ensuring Access to General Surgery H. Res 282 - Sunscreen in Schools Independent Payment Advisory Board (IPAB) Critical Access Hospitals Meaningful Use Reforms Emergency Medical Treatment and Labor Act (EMTALA) Affordable Care Act (ACA) MACRA Proposed Rule Implementation Graduate Medical Education (GME) Valuation of Global Codes Bleeding Control for the Injured (Stop The Bleed campaign) General Surgery Health Professional Shortage Areas (HPSAs) Medical Liability Reform Cancer Research Military Trauma Pediatric Trauma Medicaid
Client expense: $173,003 · Firm income: Not reported
| Democratic |
| IA |
| David P. Joyce | Republican | OH |
| Elizabeth H. Esty | Democratic | CT |
| Evan H. Jenkins | Republican | WV |
| Garret Graves | Republican | LA |
| Henry Cuellar | Democratic | TX |
| Jacky Rosen | Democratic | NV |
| Jim Cooper | Democratic | TN |
| John Garamendi | Democratic | CA |
| Julia Brownley | Democratic | CA |
| Madeleine Z. Bordallo | Democratic | GU |
| Patrick Meehan | Republican | PA |
| Raja Krishnamoorthi | Democratic | IL |
| Rosa L. DeLauro | Democratic | CT |
| Ruben Gallego | Democratic | AZ |
| Salud O. Carbajal | Democratic | CA |
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $470,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $470,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $24,800 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $24,800 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $180,300 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $180,300 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)